We are recruiting a Bioprocess Expert in Antibody-Drug Conjugates (ADC) and next generation conjugates (“XDC” such as BsADCs, Dualpayload ADCs, AOCs…) for CMC on a permanent contract for our Toulouse site (Oncopole, 31), reporting to Pierre Fabre Pharma's R&D Department.
You will be responsible for the development of drug substance (ADC-DS) and manufacturing of new ADC and biologic drug candidates.
This includes the development, optimization, and characterization of bioprocesses for ADCs by defining and executing CMC strategy for these preclinical and clinical programs, ensuring robust, compliant manufacturing processes and high-quality clinical and commercial supplies.